// App-Quantinova.ai

: Allogeneic Transplantation for Minimal Residual Disease Negative Acute Lymphoblastic Leukemia According to 2016 Who Classification: A Single Center Retrospective Analysis

Researchers

Presenter

  • Xingyu Cao

Principal Investigators

  • Deyan Liu

  • Jianping Zhang

  • Zhijie Wei

  • Min Xiong

  • Yue Lu

  • Yanli Zhao

  • Jiarui Zhou

  • Ruijuan Sun

  • Hongxing Liu

Medical Centers

  • Bone Marrow Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang, China

  • bone marrow transplant department, hebei yanda ludaopei hospital, langfang, China

  • Pathology & Laboratory Medicine Division, Lu Daopei Hematology & Oncology Center, Hebei Yanda Hospital, Beijing, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • B-cell acute lymphoblastic leukemia

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • Cluster of Differentiation 2AP

  • Cluster of Differentiation 34

  • Histone-lysine N-methyltransferase 2A

Drug/Treatment

  • Allopurinol

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved